Clinicopathological significance of identifying glypican 3 -positive gastric cancer
Pathology - Research and Practice · 2025
DOI: 10.1016/j.prp.2025.156089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Hai-Fen Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: mhfen@163.com. Hauptthemen laut MEDLINE: Stomach Neoplasms, Glypicans, Adenocarcinoma, Biomarkers, Tumor. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ningbo Municipal Natural Science Foundation.
Abstract (Originalsprache)
OBJECTIVE: The aim of this study was to investigate the expression of Glypican 3 (GPC3) in gastric cancer and to identify clinicopathological prognostic factors associated with GPC3-positive gastric cancer (GPC3-GC). METHODS: Gene expression and survival differences of GPC3 were analyzed by the TCGA-STAD database and immunohistochemical detection in the gastric adenocarcinoma tissues. RESULTS: Bioinformatic analysis revealed that the GPC3 gene was highly expressed in gastric adenocarcinoma tissues (P 0.05). Cox regression analyses identified GPC3-positive as a risk factor affecting postoperative prognosis in gastric adenocarcinoma (P 0.05). CONCLUSION: GPC3 is expressed in some cases of gastric adenocarcinoma, particularly in cancers with elevated serum AFP levels, providing a potential basis for clinical monitoring and exploring new immunotherapy targets. GPC3-GC often exhibits strong invasive and metastatic capabilities and may carry a poor prognosis, especially in cases with enteroblastic differentiation and elevated serum AFP. Therefore, it is crucial to enhance awareness and differentiate GPC3-GC from common adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: mhfen@163.com.
- Department of Emergency, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: 1445383396@qq.com.
- Department of Pathology, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: ljqiang2810@163.com.
- Department of Pathology, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: merry999@126.com.
- Department of Pathology, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: hua2577@126.com.
- Molecular Laboratory, Beilun People's Hospital, Ningbo, Zhejiang Province 315800, China. Electronic address: 961576995@qq.com.
Förderung
- Ningbo Municipal Natural Science Foundation
Zitieren
APA
Ma, H. F., Li, Z. N., Li, J. Q., Wang, M., Xiao, W. H., Shu, P., & Shi, X. H. (2025). Clinicopathological significance of identifying glypican 3 -positive gastric cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156089
Vancouver
Ma HF, Li ZN, Li JQ, Wang M, Xiao WH, Shu P, et al. Clinicopathological significance of identifying glypican 3 -positive gastric cancer. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156089
BibTeX
@article{Ma2025,
author = {Ma, Hai-Fen and Li, Zi-Ning and Li, Jun-Qiang and Wang, Min and Xiao, Wei-Hua and Shu, Peng and Shi, Xiao-Hai},
title = {Clinicopathological significance of identifying glypican 3 -positive gastric cancer},
journal = {Pathology - Research and Practice},
year = {2025},
doi = {10.1016/j.prp.2025.156089}
}
EUVIMED